Clinical Research Malaysia

What Clinical Research Malaysia does

Clinical Research Malaysia (CRM) is a Global Trusted Research Management Organisation established by the Ministry of Health Malaysia in 2012, operating as a government-linked non-profit trust rather than a commercial enterprise. It provides end-to-end clinical trial support services to global pharmaceutical sponsors, Contract Research Organisations (CROs), and Malaysian clinical investigators, including site management, study coordination, CTA review facilitation, feasibility management, and patient recruitment across a network of Malaysian public hospital trial sites. Its primary customers are multinational pharmaceutical sponsors (named anchors include Roche, AstraZeneca, and Novo Nordisk) and Malaysian investigators operating in public hospitals; secondary segments include patients reached via the I AM AWARE public awareness campaign.

CRM's product and technology surface consists of an internal coordination portal (CRMx, providing ISR Central and Feasibility Central functionality for study coordinators), a public statistics platform (FACT Portal), a quarterly professional newsletter (Q-bites), a training and career development programme (Centre of Excellence), a public awareness campaign (I AM AWARE), and an annual industry conference (CRM Trial Connect). The technology is described as a clinical research management and coordination platform rather than a unified software product, and no AI/ML capabilities are referenced. Revenue is generated through service fees charged to pharmaceutical sponsors and CROs for clinical trial management support, supplemented by government backing from the parent Ministry of Health Malaysia; pricing is not publicly disclosed. Go-to-market is direct enterprise engagement with global sponsors and CROs, complemented by community events and public awareness campaigns. The organisation holds ISO 9001:2015 (QMS, since 2019) and ISO 37001:2016 (ABMS, since 2021) certifications, maintains a 14-day CTA review timeline since 2017, and is a member of the International Clinical Trial Center Network (ICN) spanning five continents.

Name

Clinical Research Malaysia

Legal name

Clinical Research Malaysia

Website

https://clinicalresearch.my

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

Clinical Research Malaysia (CRM) is a government-linked, non-profit clinical research management organisation established in 2012 by Malaysia's Ministry of Health. It provides end-to-end clinical trial support, including site management, study coordination, and regulatory facilitation, to global pharmaceutical sponsors, CROs, and Malaysian investigators.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Clinical trial management
• Site management organization
• Clinical research support
• Patient recruitment services
• Regulatory CTA review

Headquarters

HQ city

Kuala Lumpur

HQ country

Malaysia

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others, Infrastructure, Marketing or Sales

Revenue model

1. Clinical trial support services: CRM provides end-to-end clinical research support services to pharmaceutical sponsors and CROs, including site management, study coordination, CTA review facilitation, feasibility management, and patient recruitment services. Revenue is generated through service fees charged to sponsors for clinical trial management support.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Clinical Research Malaysia provides end-to-end clinical trial support services to global pharmaceutical sponsors and Contract Research Organisations (CROs) conducting clinical research in Malaysia. Its core services encompass site identification and management, study coordination support via trained study coordinators, Clinical Trial Agreement (CTA) review facilitation with a 14-day turnaround, feasibility study management, and patient recruitment. The organisation was established by Malaysia's Ministry of Health in 2012 and operates across a network of Malaysian public hospital trial sites.

Product overview

Clinical Research Malaysia offers a portfolio of clinical trial management and support services, comprising core platforms including CRMx (internal study coordinator portal for ISR and feasibility management), the FACT Portal (public statistics portal), and Centre of Excellence (training and professional development). Supporting offerings include Q-bites newsletter (quarterly GCP/ethics guidance publication), the I AM AWARE public awareness campaign, and the CRM Trial Connect annual conference. The organization, established by Malaysia's Ministry of Health in 2012, provides end-to-end clinical research support rather than a single unified software product.

Differentiator

Problem solved

Functional benefit

Products and services

• End-to-End Clinical Trial Support Services End-to-end clinical research support services to global pharmaceutical sponsors and CROs conducting trials in Malaysia, including site identification and management, study coordinator support, Clinical Trial Agreement (CTA) review with 14-day turnaround, feasibility study management, patient recruitment, and regulatory facilitation across Malaysian public hospital trial sites.

Quantifiable outcome

• 83% average recruitment rate in 2025 for studies managed by CRM
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Global Antibiotic Research and Development Partnership (GARDP)coreStrategic or Co-development Partner · 1 January 2025CRM partnered with GARDP to build a resilient healthcare future through collaboration on antimicrobial resistance (AMR) clinical research, aimed at advancing the development of new antibiotics and health solutions.
• AstraZenecacoreStrategic or Co-development Partner · 1 January 2024CRM and AstraZeneca entered a strategic MoU resulting in the UK-Malaysia Partnership of the Year Award 2024. The partnership included the strategic move of the clinical research management team to Malaysia, a significant increase in clinical trials in 2023, and the initiation of a First-in-Human (FIH) study, contributing to Gross National Income (GNI).
• International Clinical Trial Center Network (ICN)coreStrategic or Co-development PartnerCRM is a member of ICN, a multinational network connecting excellence in clinical research across 5 continents. ICN is built on core values of Global, Excellence, Harmonization and Impacts, and promotes better clinical research through open knowledge exchange and enhancement of research capabilities worldwide.
• Roche PharmaceuticalsminorStrategic or Co-development PartnerRoche Pharmaceuticals selected Sarawak General Hospital as a site for its global First-in-Human (FIH) clinical trial, with CRM facilitating and supporting the trial at the Malaysian site.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Parexel International: Major global CRO with broad clinical trial services and Asia-Pacific operations. Comparable to CRM as a sponsor-facing trial services provider, but as an incumbent with much wider geographic and service breadth.
• ICON plc: Major global CRO providing end-to-end clinical trial services. Comparable to CRM in service offering but as a broad incumbent serving sponsors worldwide with much larger operational scale.
• Medpace: Global mid-to-large CRO with strong therapeutic expertise. Broad incumbent competing with CRM in clinical trial execution for pharma sponsors, though Medpace operates globally rather than regionally.
• IQVIA: World's largest CRO with global clinical trial operations including presence in Asia-Pacific. Broad incumbent that competes with CRM for global sponsor business but operates at vastly greater scale across many geographies.

Emerging players

• Worldwide Clinical Trials: Mid-sized global CRO focused on complex therapeutic areas. Comparable to CRM in serving pharma sponsors with clinical trial management services, though Worldwide operates globally rather than regionally in Asia.
• Celerion: Early-phase clinical research organization with focus on First-in-Human and bioequivalence studies. Comparable to CRM in its FIH trial focus, though Celerion operates its own clinics rather than coordinating through a national hospital network.

Regional players

• EPS Holdings: Japanese CRO/SMO providing site management and clinical trial support. Comparable to CRM in its SMO-style site coordination and patient recruitment focus, but operating in Japan.
• Tigermed: Leading Chinese CRO offering comprehensive clinical trial services. Comparable to CRM as an Asia-based CRO serving global pharma sponsors, though focused on China rather than Southeast Asia.
• CMIC Holdings: Japan's largest CRO with end-to-end clinical trial services. Comparable to CRM in service breadth (site management, patient recruitment, regulatory facilitation) but operates in Japan rather than Malaysia.

Direct peers

• Novotech Health Holdings: Asia-Pacific-focused CRO providing clinical trial services across the region. Directly comparable to CRM as both serve global sponsors seeking to run trials in Asia with regional site networks and regulatory expertise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/clinicalresearchmalaysia
• Xx.com/ClinicalRsrchMY
• LinkedInlinkedin.com/company/clinical-research-malaysia

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Research Malaysia